UniQure's Huntington's gene therapy reportedly slows progression after four years
STAT reports that the therapy's benefit was smaller than in a similar analysis from a year earlier, though it continued to slow progression at four years.
TLDR
STAT reports that UniQure's gene therapy continued to slow Huntington's disease progression after four years. The magnitude of the benefit was smaller than in a similar analysis from a year earlier.
Combined views
1.2K
1 Source, first seen 1h ago
8 likes